Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot study

The lack of biomarkers to monitor and predict the efficacy of electroconvulsive therapy (ECT) has hindered its optimal use. To establish metabolomic markers for monitoring and predicting the treatment efficacy of ECT, we comprehensively evaluated metabolite levels in patients with major depressive d...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Takahito, Sugiura, Yuki, Sugiyama, Eiji, Maeda, Rae, Tanaka, Kenji F., Suematsu, Makoto, Mimura, Masaru, Uchida, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425446/
https://www.ncbi.nlm.nih.gov/pubmed/37580528
http://dx.doi.org/10.1038/s41598-023-40498-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425446/
https://www.ncbi.nlm.nih.gov/pubmed/37580528
http://dx.doi.org/10.1038/s41598-023-40498-7

Ejemplares similares